Well spotted - Neuren engaging in the same sort of outreach to the PMS community as it did with Retts during stage 2 trials.
Ann: P2 trial shows significant improvements in Phelan-McDermid, page-209
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.71 |
Change
-0.250(1.93%) |
Mkt cap ! $1.574B | |||
| Open | High | Low | Value | Volume |
| $12.82 | $13.05 | $12.53 | $5.188M | 404.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 259 | $12.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.72 | 464 | 13 |
View Market Depth
| Last trade - 15.35pm 17/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |